Eye2Gene
PrivateLast Round
Seed
Nov 19, 2025
Total Funding Raised
$2.73M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Eye2Gene is a healthcare technology company that has developed a precision ophthalmology platform to improve the diagnosis of genetic eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Precision Medicine, Clinical Trials, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eye2Gene Comparables
Compare Eye2Gene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| deepeye Medical | 74% | |
| Altris AI | 72% | |
| Topcon Corporation | 69% |
Eye2Gene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 19, 2025 | ||||
| Grant | May 8, 2025 | ||||
| Grant | Jun 16, 2021 |
Eye2Gene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Medical Research Foundation | Grant |
| Department of Health and Social Care | Grant |
| NHS AI Lab | Grant |
| NHS Accelerated Access Collaborative | Grant |
| National Institute for Health and Care Research | Grant |
| Twin Path Ventures | Seed |
| Moorfields Eye Charity | Grant, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2025
$921K raised with Twin Path Ventures participating.
- May 8, 2025
Received grant funding from Medical Research Foundation, Moorfields Eye Charity, and Sight Research UK.
Eye2Gene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Eye2Gene's valuation, stock price, and market status.
Is Eye2Gene a public or private company?
Eye2Gene is a private company.
What is the current stock price of Eye2Gene?
Eye2Gene is a private company, so its shares have no public market price. Caplight tracks Eye2Gene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eye2Gene worth (valuation)?
Valuation information for Eye2Gene is not publicly available.
Can I buy Eye2Gene stock?
Eye2Gene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eye2Gene's last funding round?
Eye2Gene's most recent funding round was Seed on November 19, 2025.
Who are the main investors in Eye2Gene?
Key investors in Eye2Gene include Medical Research Foundation, Department of Health and Social Care, NHS AI Lab, NHS Accelerated Access Collaborative, National Institute for Health and Care Research.
Will Eye2Gene IPO soon?
No public IPO plans have been announced for Eye2Gene.
How can I track Eye2Gene secondary market activity?
Caplight tracks bids, offers, and trades in Eye2Gene's shares on secondary markets.